One Expert from Early- through Late-Stage Trials
IMAGING CRO (CORE LAB) SERVICES:
- We provide comprehensive imaging services and technology solutions throughout the clinical trial process.
- Our experience spans hundreds of successful trials, including some of the most high-profile global registration trials and novel new drug approvals in the industry.
- Global leader in real-time image receipt, query management and reads from hundreds of sites in over thirty countries.
- State-of-the-art cloud-based systems enable us to provide real-time reads for rapid decisions.
DEEP IMAGING SERVICES:
- We integrate more powerful imaging technologies into clinical studies.
- Our advanced imaging helps identify biological activity where traditional imaging fails.
- Pioneer and global leader in customized criteria, advanced imaging, biomarker development, radiomics and artificial intelligence.
- Pioneer and global leader in unique imaging such as: tumor microenvironment imaging, molecular imaging, 3D virtual reconstruction imaging and theragnostic development.
News
Imaging Endpoints’ O’Malley recognized as finalist for 2020 Arizona Corporate Counsel Award
Virginia O’Malley, Imaging Endpoints’ Vice President and General Counsel was recognized as a finalist for the 2020 Arizona Corporate Counsel Award for the Technology Company category at a recent ceremony… Read More
Breakthrough Radiomic Technology Patent Issued to Imaging Endpoints
Imaging Endpoints announced today that the U.S. Patent and Trademark Office has issued Patent No. 10,332,634 – “Systems And Methods For Reliably Diagnosing Breast Cancer Using Quantitative Textural Analysis” to… Read More
Imaging Endpoints Assists FORMA Therapeutics As Olutasidenib Demonstrates Positive Phase 1b/2 Results, Including Blood-Brain Barrier Penetration And Stable Disease In Patients With IDH1-Mutated Glioma.
Imaging Endpoints Assists FORMA Therapeutics as Olutasidenib Demonstrates Positive Phase 1b/2 Results, Including Blood-Brain Barrier Penetration And Stable Disease In Patients With IDH1-Mutated Glioma. The Data Was Recently Presented at… Read More
Events
-
Wed26Feb2020Fri28Feb2020Crowne Plaza Times Square, New York City, NY, USA
-
Fri24Apr2020Wed29Apr2020San Diego Convention Center, San Diego, California
-
Sat25Apr2020Fri01May2020Toronto, CA